About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) is a Healthcare company in the Pharmaceutical Preparations industry with a market capitalisation of $77.9B. The stock trades at 18.17x trailing earnings and yields 0.5%.
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Market cap
- $77.9B
- P/E ratio
- 18.17
- EPS (TTM)
- $41.48
- Revenue (TTM)
- $14.3B
- Free cash flow
- $4.1B
- Profit margin
- 31.4%
- Dividend yield
- 0.5%
- Shares outstanding
- 94M
Financial health: Strong8.5/10
7 strengths, 0 concerns. No red flags against these benchmarks.
- Debt to equity: 0.06 (Strong, benchmark < 0.5) — Debt of 0.06x equity is conservative against the 0.5x benchmark. It has improved over the last 4 years.
- Net debt vs cash flow: 0.0y (Strong, benchmark < 4 years) — Holds more cash than debt ($1.1B net cash).
- Current ratio: 4.13 (Strong, benchmark > 1.5) — Short-term assets cover 4.13x short-term liabilities, against Graham's 1.5x floor. It has deteriorated over the last 4 years.
- Return on equity: 14.4% (Watch, benchmark > 15%) — Earns 14.4% on shareholder equity, short of the > 15% mark.
- Gross margin: 84.9% (Strong, benchmark > 40%) — Keeps 84.9% of revenue after the direct cost of sales, comfortably past the > 40% mark.
- Net margin: 31.4% (Strong, benchmark > 10%) — Turns 31.4% of revenue into profit, comfortably past the > 10% mark.
- Free cash flow: $4.1B (Strong, benchmark positive) — Generated $4.1B of free cash flow after capital spending. It has been broadly flat over the last 4 years.
- Revenue growth: 1.0% (Watch, benchmark > 10%) — Revenue changed 1.0% year on year, short of the > 10% mark.
- Earnings growth: 2.1% (Watch, benchmark > 10%) — Earnings changed 2.1% year on year, short of the > 10% mark.
- Payout ratio: 8.2% (Strong, benchmark < 60%) — Pays out 8.2% of earnings as dividends, leaving room to keep paying.